Mid Ohio Oncology/Hematology, Inc. is a clinical research site located in Columbus, Ohio, United States 43215.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Mid Ohio Oncology/Hematology, Inc. has participated in 6 clinical trials.
Therapeutic areas: Multiple Myeloma, Prostate Cancer, Colorectal Neoplasms.
Sponsors: Accelerated Community Oncology Research Network, Novacea, Novartis.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Mid Ohio Oncology/Hematology, Inc. has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid Ohio Oncology/Hematology, Inc. has 6 clinical trials on record. Their work covers Multiple Myeloma, Prostate Cancer, Colorectal Neoplasms.
Yes — Mid Ohio Oncology/Hematology, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.